Lauriad® is an innovative technology for high-performance delivery.
Lauriad®: a new cutting edge technology with the potential of improving the use and efficiency of existing API.
Lauriad®'s targeted action avoids the first-pass hepatic effect:
- Limitation of drug interactions and adverse effects
Lauriad®’s targeted action avoids gastrointestinal enzymatic degradation
Lauriad® technology enables a targeted action at the site of infection by releasing an early, effective and prolonged concentration of an active substance:
- Limitation of doses
- Improving compliance
- Improving treatment outcomes
- ecology of drug taking